Table 2.
Prevalence of viral hepatitis and HIV infection.
| Parameter | HBsAg (+) | anti-HCV (+) | anti-HDV (+) | HIV (+) |
|---|---|---|---|---|
| At initial screening (N = 118) | 12 (10.2%) | 19 (16.1%) | 1 (8.3%)a | 2 (1.7%) |
| Subsequent screenings (N = 118) | 13 (11%) | 36 (30.5%) | 1 (7.7%)b | 2 (1.7%) |
| Sex: Males (N = 79) Females (N = 39) |
9 (11.4%) 4 (10.3%) |
26 (32.9%) 10 (25.6%) |
1 (1.3%) 0 (0%) |
2 (2.6%) 0 (0%) |
| History of blood transfusion (N = 68) | 9 (13.2%) | 26 (38.2%) | 0 (0%) | 2 (2.9%) |
| Duration of HD | ||||
| <1 year (N = 71) | 7 (9.9%) | 13 (18.3%) | 1 (1.4%) | 2 (2.8%) |
| >1 year (N = 47) | 6 (12.8%) | 23 (48.9%) | 0 (0%) | 0 (0%) |
a
1 patient of 12 HBsAg positive patients.
b
1 patient of 13 HBsAg positive patients.